Dog /

Breed profile · FDA CVM July 2026 extract

Sheepdog - Maremma and Abruzzes adverse-event record

Adverse-event filings for Sheepdog - Maremma and Abruzzes (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#324 of 510
by report volume (all breeds)
29
FDA CVM reports on file
0.0%
death-coded share of reports
7
Lack of efficacy (endoparasite) - heartworm - top reaction

How the 29 reports break down

By recorded gender -- every report on file for Sheepdog - Maremma and Abruzzes, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 5 3.75 2.5 1.25 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Sheepdog - Maremma and Abruzzes drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Sheepdog - Maremma and Abruzzes ranks #323 of 510 by total reports (29). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#323
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Sheepdog - Maremma and Abruzzes has 29 reports now versus 29 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Sheepdog - Maremma and Abruzzes changes

Total Reports

29

Below-median volume

Deaths Reported

0

of 29 reports

Death-coded share of reports

0.0%

0.0% death-coded

Avg Age at Report

3.7 yr

41.1 kg avg weight

Death-Coded Outcome Share

Sheepdog - Maremma and Abruzzes death-coded reports 0.0%
Cross-breed median

0.0% of 29 sheepdog - maremma and abruzzes reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 41.1 kg (90.6 lbs)

Top Reported Reactions

Lack of efficacy (endoparasite) - heartworm 7
Lack of efficacy (bacteria) - Borrelia 5
Lethargy (see also Central nervous system depression in 'Neurological') 2
Scratching 2
Panting 2

Most Referenced Drugs

Pyrantel Pamoate;Sarolaner 7
Milbemycin Oxime + Spinosad 3
Oclacitinib Maleate 3
Ivermectin + Pyrantel As Pamoate Salt 3
Moxidectin 3

Outcome Breakdown

Ongoing
17 (58.6%)
Recovered/Normal
5 (17.2%)
Outcome Unknown
5 (17.2%)
Recovered with Sequela
2 (6.9%)

Gender Distribution

Male 20 (69.0%)
Female 9 (31.0%)

Reports by Year

Year Reports Trend
2014 1
2015 1
2016 1
2017 1
2018 1
2019 3
2020 1
2021 5
2022 5
2023 3
2024 5
2025 2

Sheepdog - Maremma and Abruzzes: low death-coded share in the FDA CVM extract

Signature read: Sheepdog - Maremma and Abruzzes's 0.0% death-coded share is in the lower third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Sheepdog - Maremma and Abruzzes sits at #324 of 510 by report volume among all breeds and #215 of 298 among dog breeds, with 29 reports and 0 (0.0%) death-coded. Mean age at report: 3.7 years, average weight 41.1 kg (90.6 lbs).

Top reported signs: Lack of efficacy (endoparasite) - heartworm (7), Lack of efficacy (bacteria) - Borrelia (5), Lethargy (see also Central nervous system depression in 'Neurological') (2). Most-referenced drug: Pyrantel Pamoate;Sarolaner (7 reports), followed by Milbemycin Oxime + Spinosad (3) and Oclacitinib Maleate (3).

Outcome coding on 29 status-recorded reports is dominated by Ongoing (58.6%). Annual submissions ranged 1-2,025 across 12 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Sheepdog - Maremma and Abruzzes, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar average weight

Nearest other-species breeds by reported average weight (41.1 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Sheepdog - Maremma and Abruzzes?
There are 29 adverse event reports involving Sheepdog - Maremma and Abruzzes in the FDA database, of which 0 were death-coded (0.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Sheepdog - Maremma and Abruzzes ranks #324 of 510 by report volume among all breeds PlainBreed indexes (#215 of 298 among dog breeds).
Where does Sheepdog - Maremma and Abruzzes sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Sheepdog - Maremma and Abruzzes is #324 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #215 of 298. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Sheepdog - Maremma and Abruzzes?
The most commonly reported adverse reactions for Sheepdog - Maremma and Abruzzes are Lack of efficacy (endoparasite) - heartworm (7 reports), Lack of efficacy (bacteria) - Borrelia (5 reports), Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Scratching (2 reports), Panting (2 reports).
What drugs are most frequently associated with Sheepdog - Maremma and Abruzzes adverse events?
The drugs most frequently referenced in Sheepdog - Maremma and Abruzzes adverse event reports are Pyrantel Pamoate;Sarolaner (7 reports), Milbemycin Oxime + Spinosad (3 reports), Oclacitinib Maleate (3 reports), Ivermectin + Pyrantel As Pamoate Salt (3 reports), Moxidectin (3 reports).
What is the average age of Sheepdog - Maremma and Abruzzes in adverse event reports?
The average age of Sheepdog - Maremma and Abruzzes at the time of adverse event reports is 3.7 years, with an average weight of 41.1 kg (90.6 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Sheepdog - Maremma and Abruzzes (Dog), extract as of July 2026 extract. 29 reports · 0 death-coded (0.0% of reports, not a mortality rate) · #324 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →